L. K. Dunnwald

发表

Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer.

D. Mankoff, H. Linden, R. Livingston, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer.

Julie R. Gralow, David A. Mankoff, Robert B. Livingston, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy.

Robert B Livingston, David A Mankoff, Hannah M Linden, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Dynamic and Static Approaches to Quantifying 18F-FDG Uptake for Measuring Cancer Response to Therapy, Including the Effect of Granulocyte CSF

Paul E Kinahan, Mark Muzi, David A Mankoff, 2007, Journal of Nuclear Medicine.

SUV varies with time after injection in (18)F-FDG PET of breast cancer: characterization and method to adjust for time differences.

Paul Kinahan, D. Mankoff, S. Beaulieu, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

PET Tumor Metabolism in Locally Advanced Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: Value of Static versus Kinetic Measures of Fluorodeoxyglucose Uptake

D. Mankoff, H. Linden, R. Livingston, 2011, Clinical Cancer Research.

Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy.

Robert B Livingston, David A Mankoff, D. Mankoff, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Title Assessment of a statistical AIF extraction method for dynamic PET studies with 15 O water and 18 F fluorodeoxyglucose in locally advanced breast cancer patients

R. Doot, M. Muzi, L. Peterson, 2018 .

Abstract P4-01-01: Serial FDG and 18F-fluoride PET predict response to therapy in patients with breast cancer bone metastases

D. Mankoff, H. Linden, W. Barlow, 2013 .

[Tc-99m]-sestamibi uptake and washout in locally advanced breast cancer are correlated with tumor blood flow.

D. Mankoff, R. Livingston, J. Gralow, 2002, Nuclear medicine and biology.

Internal Mammary Nodal Chain Drainage Is a Prognostic Indicator in Axillary Node-Positive Breast Cancer

D. Mankoff, B. Kurland, D. Byrd, 2007, Annals of Surgical Oncology.

Are we ready for dedicated breast imaging approaches?

Paul Kinahan, D. Mankoff, L. K. Dunnwald, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Between-Patient and Within-Patient (Site-to-Site) Variability in Estrogen Receptor Binding, Measured In Vivo by 18F-Fluoroestradiol PET

D. Mankoff, H. Linden, B. Kurland, 2011, The Journal of Nuclear Medicine.

Evaluation of the Internal Mammary Lymph Nodes by FDG-PET in Locally Advanced Breast Cancer (LABC)

D. Mankoff, J. Bellon, W. Eubank, 2004, American journal of clinical oncology.

Sentinel lymph node mapping for breast cancer: analysis in a diverse patient group.

D. Mankoff, J. Eary, B. Anderson, 1999, Radiology.

Internal Mammary Lymph Node Drainage Patterns in Patients With Breast Cancer Documented by Breast Lymphoscintigraphy

D. Mankoff, J. Eary, D. Byrd, 2001, Annals of Surgical Oncology.

Utility and reproducibility of semiquantitative analysis of sestamibi breast images.

D. Mankoff, L. K. Dunnwald, S. Hartnett, 1997, Journal of nuclear medicine technology.

Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients

M. Rossing, Christopher I. Li, L. K. Dunnwald, 2007, Breast Cancer Research.

Serial 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP)

D. Mankoff, H. Linden, R. Livingston, 2007, Breast Cancer Research and Treatment.

Tumor Metabolism and Blood Flow as Assessed by Positron Emission Tomography Varies by Tumor Subtype in Locally Advanced Breast Cancer

D. Mankoff, H. Linden, R. Livingston, 2010, Clinical Cancer Research.

Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma.

D. Mankoff, J. Eary, R. Livingston, 2000, Cancer.

Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma

D. Mankoff, J. Eary, R. Livingston, 2000 .

Technical aspects of sentinel node lymphoscintigraphy for breast cancer.

D. Mankoff, J. Eary, B. Anderson, 1999, Journal of nuclear medicine technology.

Residual tumor uptake of [99mTc]‐sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival

Robert B Livingston, David A Mankoff, Hannah M Linden, 2005, Cancer.

Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]‐sestamibi scintimammography

D. Mankoff, R. Livingston, J. Gralow, 1999, Cancer.

Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET.

D. Mankoff, W. Eubank, J. Eary, 2002, Radiographics.

Changes in Glucose Metabolism and Blood Flow Following Chemotherapy for Breast Cancer.

D. Mankoff, L. K. Dunnwald, 2006, PET clinics.

Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapy.

D. Mankoff, R. Livingston, J. Gralow, 2002, Academic radiology.

Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancer.

D. Mankoff, C. Lehman, S. Partridge, 2008, Academic radiology.

18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy.

Mark Muzi, Satoshi Minoshima, David A Mankoff, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Assessment of a statistical AIF extraction method for dynamic PET studies with 15O water and 18F fluorodeoxyglucose in locally advanced breast cancer patients

Mark Muzi, Finbarr O’Sullivan, Jian Huang, 2017, Journal of medical imaging.

Blood Flow-Metabolism Mismatch: Good for the Tumor, Bad for the Patient

D. Mankoff, S. Partridge, L. K. Dunnwald, 2009, Clinical Cancer Research.

SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors

E. Mittra, A. Kjaer, D. Taïeb, 2023, The Journal of Nuclear Medicine.

Association between serial dynamic contrast‐enhanced MRI and dynamic 18F‐FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer

Xiaoyu Chai, David A Mankoff, Brenda F Kurland, 2010, Journal of magnetic resonance imaging : JMRI.

Between-Patient and Within-Patient (Site-to-Site) Variability in Estrogen Receptor Binding, Measured In Vivo by 18F-Fluoroestradiol PET

D. Mankoff, H. Linden, B. Kurland, 2011, The Journal of Nuclear Medicine.